Peptides for Ultra-Runners: 100-Mile Recovery
Ultra-distance breaks the body in ways road racing never does: race-day gut shutdown, IT-band and tendon overuse, deep muscle damage, a post-race immune dip, and wrecked sleep. Here is how MOTS-c, BPC-157, NAD+, and Thymosin Alpha-1 map to each, with an honest read on WADA and on what training still has to do.

In this article
Key Takeaways
- Ultra-distance is a different problem from general endurance. On top of the aerobic demand, 100 miles adds race-day gut shutdown, overuse tendinopathy, deep muscle breakdown, a temporary post-race immune dip, and disrupted sleep. Four peptides map to those distinct failure modes.
- The gut is the ultra-specific angle. Prolonged effort shunts blood away from the intestine, damages the lining, and raises permeability (the "leaky gut" behind race-day nausea and cramping). BPC-157 has a mostly preclinical research base for protecting and repairing the gastrointestinal lining, and it doubles as the tendon and IT-band tool for overuse load.
- MOTS-c supports the mitochondrial engine, NAD+ supports cellular recovery between the biggest efforts, and Thymosin Alpha-1 is an immune-modulating peptide used in the post-race window when immune markers dip.
- MOTS-c and BPC-157 are both on the WADA Prohibited List and prohibited at all times. Most trail and road ultras do not test, so for recreational and masters runners the testing risk does not apply, but everything here is prescription-only. Check your status with your provider before any sanctioned race.
- This is a recovery and adaptation layer, not a way around the training. No peptide replaces the long runs, the back-to-backs, the trained gut, and the vertical. If the base is not there, peptides are not what is missing.
Ultra-Runner Peptide Protocol at a Glance
The problem
100 miles breaks the body in five ways at once, not one
The engine
MOTS-c, mitochondrial endurance for deep aerobic efforts
The gut and tendons
BPC-157, GI lining plus IT-band and Achilles overuse
Between efforts
NAD+, cellular recovery after the biggest weeks
Post-race immunity
Thymosin Alpha-1, immune support in the recovery window
Administration
All subcutaneous injection, prescription-only in the US
Mile 62, and the Stomach Quits
The scene
You are 62 miles in. The legs are tired but honest, the pacing has been disciplined, the climbs are done. Then the stomach turns. Not hunger, not a stitch. The deep, roiling nausea where every gel you force down comes right back up, the aid-station broth will not stay put, and the math on your calories per hour is quietly falling apart. You are not bonking on fitness. You are bonking on a gut that stopped absorbing an hour ago, and there are 38 miles left.
Ask anyone who has finished, or failed to finish, a 100-miler and some version of this moment comes up. GI distress is the single most common reason runners drop from 100-mile races, ahead of injury and ahead of pace. The fitness is rarely the thing that ends the day. The body that has to carry the fitness across 24-plus hours is. When you get a peptide through PeRx, it is prescribed by a licensed provider and compounded in a US-based, FDA-regulated 503A pharmacy, the same regulated pathway many everyday prescriptions go through.
Most peptide content for runners stops at general endurance. That is a real category, and we cover it in the triathlete and Ironman guide. But ultra-distance is its own beast, and lumping it in with a 70.3 or a marathon misses what actually goes wrong past hour six. This guide is built around the five things 100 miles specifically breaks, the peptides that map to each, and an honest section on anti-doping, because if you race a tested event, that part is not optional.
Why Ultra Is Not Just More Endurance
A marathon is a hard aerobic effort that ends in a few hours. An ultra is a different physiological event. The clock runs long enough that systems which hold up fine over three hours begin to fail over fifteen: the gut stops absorbing, connective tissue that tolerated a marathon build starts to grind, muscle damage accumulates past the point of same-week repair, and the immune system takes a measurable hit that a shorter race never produces.
The generic endurance advice, and the generic endurance peptide protocol, is built around the mitochondrial engine and between-session recovery. Those still matter for ultra, and MOTS-c and NAD+ carry that load here too. But if you stop there, you have ignored the two things that actually end 100-mile races: the gut and the overuse injuries. That is the gap this guide fills, and it is why the ultra protocol leans on BPC-157 and adds a post-race immune layer that a shorter-distance plan does not need.
The Four Ways 100 Miles Breaks You
Strength sport breaks down in one way, mostly: connective tissue under maximal load. A 100-miler breaks down in several ways at once, on different clocks, and each maps to a different tool.
The gut
Race-day GI shutdown
The overuse injuries
IT band, Achilles, tendon load
The engine and the muscle
Mitochondria and deep damage
The immune dip
The post-race window
The mistake is treating peptides as one interchangeable category and picking whichever one a forum thread mentioned most. Matching the molecule to the system it actually acts on is the entire point, and it is what the rest of this guide walks through.
The Gut: BPC-157 and Race-Day GI Distress
This is the ultra-specific angle, and it is the one general endurance guides skip. Over a long effort the body prioritizes blood flow to working muscle and skin, and the splanchnic circulation that feeds the gut gets cut back sharply. That hypoperfusion damages the intestinal lining, loosens the tight junctions between cells, and raises intestinal permeability. The result is the "leaky gut" of endurance: bacterial fragments cross the barrier, the immune system reacts, and the runner feels it as nausea, cramping, and the inability to keep calories down.
Costa RJS et al., "Systematic review: exercise-induced gastrointestinal syndrome, implications for health and intestinal disease," Alimentary Pharmacology & Therapeutics, 2017; 46(3):246-265. View study
That is the mechanism behind the mile-62 scene, and it is why a gut that failed is a fueling failure, not a fitness failure. It is also why BPC-157 shows up in ultra circles. BPC-157 is a synthetic peptide based on a sequence found in gastric juice, and its research base, which is largely preclinical and in animal models, centers on protecting and repairing the gastrointestinal lining. In rodent studies it protects the stomach and gut against damage and supports the repair of the intestinal wall. For a tissue that gets hammered by every long effort, that is the mechanism that makes sense.
Sikiric P et al., "Stable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye's Stress Coping Response," Gut and Liver, 2020; 14(2):153-167. View study
What it is not
BPC-157 is not a race-day rescue you swallow at mile 60, and the gut research is preclinical, not proven in racing humans. It does not replace a trained gut, a dialed carbohydrate strategy, and honest pacing, which are still the primary tools against GI distress. Think of it as a background repair layer run in training, not a patch for a fueling plan that was never tested on a long run.
Overuse: IT Band, Achilles, and Tendon Load
The second thing that ends ultra seasons is rarely a dramatic tear. It is the slow overuse injuries that build across a big volume block and then refuse to settle: the iliotibial band that lights up on long descents, the Achilles that has had enough vertical, the posterior tibial tendon, the patellar tendon. These are connective-tissue structures with limited blood supply, which is exactly why they heal slowly and why ice, rest, and a foam roller often are not enough on their own.
The same BPC-157 that supports the gut lining is the peptide most associated with this soft-tissue category. The research is again mostly preclinical, but consistent: BPC-157 appears to support angiogenesis (the growth of new blood vessels into healing tissue) and to speed the repair of tendon and ligament in animal models. For structures starved of blood flow to begin with, the angiogenesis mechanism is the part that makes mechanistic sense. That one peptide covers two of the biggest ultra failure modes is the reason it anchors this protocol.
The honest caution
BPC-157 is not a painkiller. It does not numb an IT band or an Achilles so you can keep loading it, and using it that way is how a manageable tendinopathy becomes a rupture. Named, localized injuries respond better than vague, all-over soreness. "My right IT band on descents" is a target. "I feel wrecked everywhere" usually means you need a cutback week, not a peptide.
The Engine: MOTS-c
MOTS-c is the peptide most directly tied to endurance itself. It was discovered at the University of Southern California in 2015, and it is notable for a strange reason: it is the first peptide ever found to be encoded by mitochondrial DNA rather than the DNA in the cell nucleus. The mitochondria, the structures that turn oxygen and fuel into ATP, make their own signaling peptide, and MOTS-c is it.
Lee C et al., "The Mitochondrial-Derived Peptide MOTS-c Promotes Metabolic Homeostasis and Reduces Obesity and Insulin Resistance," Cell Metabolism, 2015; 21(3):443-454. View study
In animal models MOTS-c behaves like an exercise mimetic. It activates the AMPK pathway, improves insulin sensitivity, and increases fat oxidation, the metabolic flexibility that lets a body burn fat efficiently deep into a long effort. For an ultra-runner, that last part is the whole game. The difference between holding your line at hour fourteen and shuffling in a fog is largely a story about fuel utilization at the mitochondrial level. A 2021 study also showed MOTS-c is released by muscle during exercise and helps regulate physical capacity with age, which lines up with why masters ultra-runners are interested in it.
Reynolds JC et al., "MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasis," Nature Communications, 2021; 12:470. View study
Timeline and testing status
MOTS-c is not a stimulant and does not produce a day-one effect. The subjective change, when runners report it, shows up on multi-hour efforts over a 3 to 6 week horizon, not on a single long run, so athletes bring it in during a base or build block rather than race week. Note that MOTS-c is on the WADA Prohibited List. If you race a tested event, read the WADA section below before anything else.
Runners training at altitude, in places like Leadville, Flagstaff, or the Colorado Front Range, sometimes start MOTS-c earlier in the build, since thin air raises the mitochondrial demand. That pattern gets its own treatment in the MOTS-c at altitude guide.
Deep Recovery: NAD+
The third system is the one nobody sees: what happens in the days between the biggest efforts, and in the weeks after a race, while muscle that took real damage rebuilds. Recovery is not passive. It is an energy-expensive cellular process, and a lot of it runs on NAD+, a coenzyme central to how cells produce and manage energy. Heavy ultra training drains the NAD+ pool faster than easy weeks do, and a depleted pool is part of why peak-block fatigue and post-race flatness feel different from ordinary tiredness.
Rajman L et al., "Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence," Cell Metabolism, 2018; 27(3):529-547. View study
NAD+ therapy is used to support that energy side of recovery during the highest-load phases and in the post-race rebuild, when deep muscle damage is being repaired. A common cadence is a maintenance dose through a build block, bumped after the biggest weekly long run or back-to-back, and elevated in the first week or two after a goal race. It pairs with the sleep and refueling that actually do most of the recovery work. No peptide outranks eight hours of sleep and adequate carbohydrate, and after 100 miles that is doubly true.
After the Finish: Thymosin Alpha-1
Ask any coach why runners so often get sick in the week after a big race and the answer is the temporary immune dip that follows extreme endurance efforts. Studies tracking runners through 100-kilometer and 100-mile events show measurable shifts in immune and blood markers right after the finish: lymphocyte counts fall while stress-response cells rise, and mucosal immunity, the first line of defense, is blunted for a window afterward. This is real, it is temporary, and it is far larger after an ultra than after a shorter race.
Kaufmann CC et al., "The Effect of a 100-km Ultra-Marathon under Freezing Conditions on Selected Immunological and Hematological Parameters," Frontiers in Physiology, 2017; 8:638. View study
Thymosin Alpha-1 is an immune-modulating peptide, a synthetic version of a fragment produced by the thymus, and it is the only thymosin PeRx sells on its own (TB-500 is thymosin beta-4, and it ships only inside combination vials). Its clinical research base is in immune support, where it is studied for its effect on T-cell maturation and function. For an ultra-runner, the interest is narrow and specific: a support layer in the post-race window when immune markers are down, not a year-round habit. It is used in the recovery phase alongside the obvious moves, more sleep, real food, and a training cutback.
King R, Tuthill C, "Immune Modulation with Thymosin Alpha 1 Treatment," Vitamins and Hormones, 2016; 102:151-178. View study
Keep the expectation honest
Thymosin Alpha-1 is an immune-modulating peptide, not a cold vaccine and not a guarantee you will dodge race-week illness. The strongest post-race immune protection is still boring: sleep, refuel, and back off training. Treat this as one recovery-phase layer, used under a provider prescription, on top of the fundamentals, not instead of them.
A Sample Protocol Arc
The peptides map to phases of the training year, not to a single daily stack. A licensed provider sets the actual protocol and dosing. What follows is the shape of how ultra-runners commonly sequence these, so you understand the logic rather than the milligrams.
How the Four Peptides Sequence Across a Build
Base and build
MOTS-c for the mitochondrial engine; BPC-157 addressing any nagging IT band, Achilles, or gut issue; NAD+ at maintenance
Peak weeks
BPC-157 daily for the gut lining and tendon load under highest volume; NAD+ bumped after the biggest long run or back-to-back
Race week (taper)
Nothing new introduced; MOTS-c to maintenance; do not dose anything novel on race morning
Race day
Execution only; no peptide is a race-day rescue, and BPC-157 is not a painkiller to push through injury
Post-race, weeks 1 to 2
NAD+ elevated for the deep-muscle rebuild; BPC-157 for anything beat up; Thymosin Alpha-1 for the immune window
Weeks -12 to -4
Build the engine
MOTS-c goes in early because it takes 3 to 6 weeks to show up subjectively. This is the block where the mitochondrial and metabolic adaptations are being built alongside the volume. BPC-157 handles whatever is grinding.
Weeks -3 to -1
Peak and taper
Highest volume, then the taper. BPC-157 works hardest here on the gut and tendons. In the final week, nothing new goes in the body. The taper applies to peptides too.
Race day
Execute
The protocol is not what gets you to the finish. Training, a trained gut, and pacing are. Do not dose anything novel on race morning. Whatever your settled routine is, that is the routine.
Weeks +1 to +2
Rebuild and defend
The high-leverage recovery window. NAD+ at an elevated dose for the deep muscle damage, BPC-157 for anything that got wrecked, Thymosin Alpha-1 for the immune dip, and easy aerobic movement before any intensity returns.
This same recovery logic drives the protocol for other long-effort endurance athletes. The gravel cyclists chasing Unbound run a very similar post-race window. Every batch is third-party tested for purity, and each order ships fully reconstituted and ready to use, delivered in refrigerated packaging.
The WADA Question (Read This)
This is the section most peptide content skips, and for anyone who races tested events it is the most important one. If your race is WADA-sanctioned, the anti-doping rules are not a footnote.
The hard facts
MOTS-c and BPC-157 are both on the WADA Prohibited List and prohibited at all times, in and out of competition. If you are subject to WADA or USADA testing, using either can produce an anti-doping rule violation. NAD+ and Thymosin Alpha-1 are not named on the current list as of the 2026 update, but the list changes every January, so this is not a permanent guarantee. Verify your exact testing status with your provider and against the current WADA Prohibited List before any sanctioned race.
Who does this actually apply to? The reality of trail and road ultras is that the large majority are not WADA-sanctioned and do not test. Most 100-mile trail races, most road ultras, and most masters and recreational events fall outside the testing system entirely, and for those runners the WADA status is informational rather than restrictive. The exceptions are IAU-sanctioned world and continental championship ultras, national-team selection events, and any race that explicitly runs under a sanctioned anti-doping code. If that is your race, treat MOTS-c and BPC-157 as off-limits during the competitive season.
What applies to everyone, tested or not: these are prescription-only substances in the US, they are not FDA-approved for performance or recovery, and getting them legally means an evaluation by a licensed provider rather than a vial from an unregulated website. Under strict liability, "I did not know" is not a defense, so the responsibility for racing clean within your category rests with you.
What This Will Not Do
Peptide therapy for ultra gets confused with several things it is not. Three honest distinctions.
Not a shortcut around training. No peptide replaces the long runs, the back-to-backs, the vertical, and the trained gut that finishing 100 miles requires. This is a recovery and adaptation layer that sits on top of the work. If the base is not there, the peptides are not what is missing, and no vial closes a fitness gap you did not build.
Not a race-day fix. None of these are things you take at an aid station to rescue a bad day. BPC-157 does not repair a shredded gut mid-race, MOTS-c does not work on the timescale of a single effort, and dosing anything new on race morning is a mistake. The work these peptides do happens in training and in recovery, not between miles 60 and 100.
Not proven in racing humans. Be honest with yourself about the evidence. Much of the BPC-157 and MOTS-c research is preclinical and in animal models, and none of it is a randomized trial in ultra-runners. The mechanisms are real and the reasoning is sound, but this is an emerging area, not settled sports medicine. Anyone promising you a guaranteed result from a vial is selling, not informing.
Peptides for Ultra Runners: Common Questions
Related Guides
Continue reading about peptides and protocols that pair well with this guide.
Peptide Therapy San Francisco: BPC-157 & More (2026)
A plain guide to peptide therapy in San Francisco: what it costs across Bay Area clinics, concierge services, and telehealth, and who tends to use it here. Plus how pharmaceutical-grade peptides reach any Bay Area address without a clinic visit.
Best Peptides for Women Over 40: What Actually Works
After 40, women face a specific set of biological changes that peptide therapy can address directly: declining growth hormone, shifting body composition, slower recovery, thinning skin, and disrupted sleep. This guide covers which peptides target these changes and what realistic results look like.
Peptides for Competitive Shooters
Precision shooting sports (USPSA, PRS, bullseye, trap) ask for steady hands, calm focus under match pressure, and stamina across a long day on the range, plus the wrist and shoulder wear that recoil leaves behind. How the Semax/Selank blend, NAD+, DSIP, and BPC-157 are used as a wellness and resilience approach for club, recreational, and masters shooters.
Ready to get started?
Pharmaceutical-grade peptides, prescribed by a licensed provider and delivered to your door with everything you need. Browse the individual peptides to read what each one does.
Medical Disclaimer
The information provided on this website, including all articles, guides, and educational content, is for informational and educational purposes only and is not intended as medical advice, diagnosis, or treatment. Nothing on this site should be construed as a substitute for professional medical advice from a qualified healthcare provider.
The majority of peptides discussed on this site are not approved by the U.S. Food and Drug Administration (FDA) for the indications described. They are classified as bulk drug substances and are available only through a licensed prescribing provider and compounding pharmacy. All treatments require a valid prescription and provider oversight.
The majority of published research on peptide therapies has been conducted in preclinical (animal) models. While early human data is encouraging, comprehensive clinical trial data remains limited for most peptide compounds. Individual results may vary significantly based on health status, injury type, and other factors. No specific outcomes are guaranteed.
Certain peptides discussed on this site are classified as prohibited substances by the World Anti-Doping Agency (WADA) and are banned by major sports organizations including the NFL, NCAA, UFC, NBA, MLB, NHL, and PGA. If you are subject to anti-doping testing, consult your governing body before considering any peptide therapy.
Statements on this website have not been evaluated by the Food and Drug Administration. Products and therapies discussed are not intended to diagnose, treat, cure, or prevent any disease.
© 2026 Wellness MD Group PC DBA PeRx. All rights reserved.